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Abstract
Gold nanoparticles (GNPs) may be used as a contrast agent to identifytumour
location and can be modified to target- and image-specific tumour biological
parameters. There are currently no imaging systems in the literature that
have sufficient sensitivity to GNP concentration and distribution measurement
at sufficient tissue depth for use in in vivo and in vitro studies. We have
demonstrated that high detecting sensitivity of GNPs can be achieved using
x-ray fluorescence; furthermore this technique enables higher depth imaging
in comparison to optical modalities. Two x-ray fluorescence systems were
developed and used to image a range of GNP imaging phantoms. The first
system consisted of a 10 mm2 silicon drift detector coupled to a slightly focusing
polycapillary optic which allowed 2D energy resolved imaging in step and scan
mode. The system has sensitivity to GNP concentrations as low as 1 ppm. GNP
concentrations different by a factor of 5 could be resolved, offering potential
to distinguish tumour from non-tumour. The second system was designed to
avoid slow step and scan image acquisition; the feasibility of excitation of
the whole specimen with a wide beam and detection of the fluorescent x-rays
with a pixellated controlled drift energy resolving detector without scanning
was investigated. A parallel polycapillary optic coupled to the detector was
successfully used to ascertain the position where fluorescence was emitted. The
tissue penetration of the technique was demonstrated to be sufficient for near-
surface small-animal studies, and for imaging 3D in vitro cellular constructs.
Previous work demonstrates strong potential for both imaging systems to form
quantitative images of GNP concentration.
Q2(Some figures may appear in colour only in the online journal)
1. Introduction
Nanoparticles (NPs) may be used as a contrast agent to identify tumours; a combination of
leaky vasculature and poor lymphatic drainage around tumour sites (an effect referred to as
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enhanced permeability and retention) results in increased NP uptake by tumour cells compared
to healthy cells (Hainfeld et al 2011). Furthermore, NPs can be attached to antibodies to actively
target key tumour characteristics in order to inform treatment options and prognosis (Popovtzer
et al 2008, Jiao et al 2011).
Gold NPs (GNPs) have readily modifiable surfaces to increase solubility (in order to
travel through the bloodstream) and enhance cell-specific uptake (Giljohann et al 2010). GNP
coating with polyethylene glycol (PEG), sodium citrate or heparin lowers acute toxicity and
sufficiently evades both host immune reactions and irreversible binding to circulating serum
proteins (Kemp and Linhardt 2010). Their high atomic number makes them an ideal contrast
medium for use in x-ray imaging techniques (Chen et al 2013, Hainfeld et al 2012, Kuang
et al 2013). Molecular imaging is also possible due to the greater number of atoms delivered
to the receptor site (∼250 Au atoms per 1.9 nm NP compared with three (monomer) or six
(dimer) I atoms per molecule when using iodinated contrast agents (Hainfeld et al 2006),
thereby increasing the signal per cell. A great advantage of using GNPs as an imaging contrast
agent for radiotherapy is that GNPs have been shown to enhance local dose deposition for both
x-ray radiotherapy (Hainfeld et al 2010, 2012, Zhang et al 2009, Jain et al 2011) and proton
radiotherapy (Kim et al 2010).
There has been a growing interest in functionalizing NPs to better target cancer treatment
and imaging (Hainfeld et al 2004, 2011, Sokolov et al 2004, Jain et al 2012, McMahon
et al 2012, Mccarthy and Weissleder 2009). These studies primarily use in vivo small-animal
studies and correlate treatment outcomes with the amount and location of NPs. Other studies
investigate uptake and distribution of NPs in 3D in vitro cellular structures, such as cellular
hydrogels and multicellular tumour spheroids (Goodman et al 2009, Grainger et al 2010);
the thickness of such in vitro samples are reported to range from 1–15 mm. It has previously
been noted by Cheong et al (2010) that the following two technical challenges are yet to be
met satisfactorily by such studies: (i) imaging of GNPs distributed within the tumour and
other critical organs, and (ii) quantification of the amount of GNPs present. We propose an
additional important challenge that must be met for GNP imaging systems: (iii) achieving a
system sensitivity capable of detecting GNP concentrations typically found in tumours. This
sensitivity will depend on tumour type, organ, stage and targeted biomarker expression. A
study that imaged the distribution of functionalized (with Herceptin) and unfunctionalized
GNP uptake in mice showed an increased uptake of the GNPs in Her2+ tumours
compared with Her2− tumours, with typical functionalized GNP concentrations ranging from
1–4 mgAu ml−1 in tumours. A high dose of GNPs (1.1 mgAu g−1) was injected into the
mouse, but other studies presented in the literature administer a much lower dose of typically
0.01 mgAu g−1 (Khlebtsov and Dykman 2011). In order for use in early stage cancer detection
a technique sensitive to less than this is required. Tumour/muscle contrast values were also
presented by Hainfeld et al (2011) with whole tumour/muscle and tumour periphery/muscle
values for functionalized (unfunctionalized) GNPs of 11.4 (8.5) and 21.8 (13.9) respectively.
A range of non-invasive GNP imaging solutions have been presented in the literature, but
none so far have met all requirements set out above. X-ray fluorescence CT (XFCT) imaging of
GNP-loaded phantoms has been successfully performed using K-x-ray fluorescence (K-XRF)
in gold (emission energies of 67 and 68.8 keV) (Cheong et al 2010). However, relatively
high GNP concentrations were tested by the system, the lowest being 5 mgAu ml−1 (three
orders of magnitude greater than that expected in vivo). Hainfeld et al were the first group
to image GNPs in vivo in mice using microCT; the mice were injected intravenously with
1.9 nm GNPs at a concentration of 2.7 mgAu g−1 (Chen et al 2013). Deliberately high Q3
amounts of gold were used to investigate x-ray contrast given by the NPs. Another group have
demonstrated that good contrast to noise CT images could be obtained at gold concentrations
An XRF imaging system for gold NP detection 3
of 0.1 mgAu ml−1 (Dilmanian et al 1997). A more recent study by Hainfeld et al (2011) reports
that microCT enables quantification of GNPs within various regions of a murine tumour; a
calibrated relationship between radiodensity and gold concentration was demonstrated down
to 0.05 mgAu ml−1. Techniques based on optical spectroscopy were found to be satisfactory
for the quantification of GNP concentration in vivo (Zaman et al 2007, Qian et al 2008), but
their use is limited to shallow sites (∼5 mm deep). Photo-acoustic imaging (Yang et al 2009)
and surface-enhanced Raman spectroscopy techniques (Keren et al 2008) have also been used
to image GNPs, along with multi-modal imaging techniques (Kircher et al 2012).
There is currently a need for an in vivo system that can penetrate to greater depths than
the aforementioned optical techniques and that is sensitive to even lower GNP concentrations
than the techniques mentioned above. We have developed a GNP imaging system based on L-
x-ray fluorescence (L-XRF) that meets the required technical challenges outlined above. It has
previously been demonstrated that the system is capable of quantitative GNP concentration
measurement down to the system detection limit of 0.001 mgAu ml−1 (Dilmanian et al 1997);
to the authors’ knowledge this sensitivity is unparalleled by any other system present in the
literature. GNP detection criteria (ii) and (iii) has therefore already been demonstrated for this
system (Dilmanian et al 1997), and so this work reports translation of the developed 1D L-XRF
spectroscopic system to a 2D imaging system to demonstrate ability to meet criteria (i). Two
proposed systems were developed and used to image a range of GNP imaging phantoms; one
consisting of a scanning spectroscopic module, the other consisting of an energy resolving
pixellated detector.
2. Materials and methods
2.1. Nanoparticle imaging phantom
A GNP imaging phantom was designed in order to assess the ability of the x-ray
fluorescence (XRF) imaging system to resolve different GNP concentrations. A concentric
ring configuration was selected, enabling one GNP concentration to be surrounded by a GNP
solution of different concentration. The phantom consisted of a series of 9 mm holes drilled
into a 10 mm thick Perspex slab; an inner hole of diameter 5 mm was drilled in the centre of
the 9 mm hole to contain a hollow cylinder of 5 mm diameter. This acted as a barrier between
the two GNP concentration solutions.
Two concentration pairings were selected: (i) a high contrast phantom consisted of
inner (outer) GNP concentrations 4 (0.2) mgAu ml−1, mimicked the difference in Herceptin-
functionalized GNP uptake in tumour periphery and muscle (20:1 contrast), at exaggerated
GNP concentration levels found in the Hainfeld et al ( 2011) mouse study, (ii) a low contrast
phantom consisted of inner (outer) GNP concentrations of 0.125 (0.025) mgAu ml−1 mimicked
unfunctionalized GNP uptake in whole tumour and muscle (5:1 contrast) at lower GNP
concentrations reported in in vivo and in vitro studies (Khlebtsov and Dykman 2011). The
outer concentration was selected to be lower than the inner concentration in each case to mimic
the in vivo situation of greater uptake in the tumour compared with uptake in surrounding
tissues.
2.2. Step and scan system
The step and scan system consisted of a 10 mm2 silicon drift detector (SDD) coupled to
a slightly focusing polycapillary optic which allowed 2D mapping in step and scan mode.
Imaging was performed at the Diamond Synchrotron Source, Didcot, UK. A laminar x-ray
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Figure 1. Contrast phantom; 9 mm hole including a straw located centrally to provide a barrier
between two different GNP concentration solutions. Right detail: high contrast phantom filled with
GNP solutions 4 mgAu ml−1 (central) and 0.2 mgAu ml−1 (outer ring); left detail: low contrast
phantom filled with GNP solutions 0.125 mgAu ml−1 (central) and 0.025 mgAu ml−1 (outer ring). Q4
beam irradiated the sample close to the sample surface (the top edge of the beam set to the
sample meniscus) to minimize self-attenuation of the fluorescence signal.
The photoelectric cross section for XRF is greatest when the exciting x-ray is just
above the absorption edge for the considered shell. The beamline energy was set to 15 keV
(above the edge for gold L-fluorescence of 11.9 keV and 13.7 keV for Lα/Lβ2 and
Lβ1 fluorescence respectively). The energy set was 1.3 keV above the highest L-edge of gold,
a compromise between optimum excitation and minimization of the impact of the Compton
shoulder background on the gold fluorescence line. The beamline collimators were set to give
a beam 4 mm wide and 4 mm high, with the top of the beam in line with the meniscus of the
sample. No filtration was added to the beam.
The SDD detection module was mounted with a 90◦ geometry in order to minimize
the Compton background, and positioned on the z-axis in line with the centre of the GNP
inclusions of the phantom. A CCD camera located behind the sample was used to monitor the
beam-sample alignment. An ionization chamber was used to monitor beam intensity in order
to normalize the data. The experimental set-up of the 2D scanning system making use of a
focusing polycapillary optic is displayed in figure 2.
2.2.1. X-ray detector system. A 10 mm2 SDD chip, produced in polysilicon technology by
PNSensor GmbH and featuring an onchip JFET, was mounted in a dedicated vacuum-tight
housing together with a Peltier cooler and dedicated front-end electronics in charge amplifier
configuration with pulsed reset developed by Politecnico di Milano, Italy, and INFN Milano
(Alberti et al 2009). The measured energy resolution was 138 eV FWHM at a shaping time
of 1 μs at 5.9 keV and a maximum count rate of the order of 105 s−1. The SDD consisted of
a 450 μm thick detector-grade silicon substrate, and gave a high efficiency of gold Lα peak
detection (97%).
The preamplifier signal was fed to a fifth-order shaping amplifier with 1 μs shaping
time constant (a measured value of 134 eV FWHM at 5.9 keV). A multichannel analyser
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Figure 2. Experimental set-up for 2D scanning system.
(MCA-8000A, Amptek Inc., MA, USA) interfaced the detector with a personal computer for
data acquisition and spectrum analysis.
2.2.2. Focusing polycapillary optics. Polycapillary lenses are monolithic structures of
bundles of hollow glass capillaries along which x-rays are guided by total external reflection
(TER) (MacDonald and Gibson 2003, Kumakhov 1990). Focusing polycapillary optics are
generally used to capture x-rays emitted from a source and focus them to a small spot area
to increase the intensity over small sample areas to enable high intensity XRF measurement.
Focusing optics are designed to have gently bending hollow capillaries of curvature smaller
than the critical angle that propagate x-rays through them to focus them to a point. According
to the physics of x-ray optics smaller focal spot sizes are expected with increasing x-ray energy
(Grassi et al 2010).
The XRF imaging system described here utilized a focusing polycapillary optic to collect
the x-rays emitted from the sample after XRF excitement, and to transport the collected x-rays
to the detector chip. The lens enabled an increased distance between the sample and detector
without a decrease in effective collection angle of the XRF x-rays. The lens also improved the
spatial resolution of the image by allowing measurement of small areas of the sample, with
particular improvements made compared with mechanical collimator techniques. The focusing
lens also enabled the detector to focus measurement at a specific depth in the sample (along the
y-axis) according to the focal point of the lens. An 84MLS11 polycapillary optic lens (Institute
for Scientific Instruments GmbH, Berlin, Germany) (figure 3) was implemented and measured
to have a nominal focusing spot size of ∼300 μm FWHM in the energy range 5–10 keV
(Grassi et al 2010).
The detector was sealed in a custom compact case, vacuum-tight down to 10−4 mbar.
The housing was sealed with an 8 μm thick beryllium entrance window (Castoldi et al 2011).
Lens parameters given by the manufacturer are as follows: capture angle 0.095 rad; capillary
diameter 30 μm; lens length 85 mm; lens curvature radius 1050 mm.
2.2.3. Gold nanoparticle imaging procedure. The beam, sample centre and SDD-optic
module were aligned. The sample was then scanned in both the x- and z-directions with
a 600 μm × 600 μm pitch to build up a pixellated image. The scanned area was
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Figure 3. (Top) 84MLS11 polycapillary optic lens (Institute for Scientific Instruments GmbH,
Berlin, Germany) in its vacuum-tight case. (Bottom) Designed vacuum-tight detection module
with the polycapillary lens (Keren et al 2008).
12 mm × 7.2 mm. An X–Y–Z micrometric stage system was responsible for sample movement
and remote control management by the DAQ enabled automatic X–Y scans. An acquisition
time of 40 s per point was taken (total imaging time 3 h) and the full energy spectrum obtained
at each point.
GNP images were reconstructed off-line by computing the integral counts under the gold
Lα and Lβ peaks. Figure 4 displays example energy spectra within the Perspex component
of the phantom, and within the 4 mgAu ml−1 GNP solution volume. It can be seen that the
background was negligible beneath the gold peaks, and so no background subtraction was
made when integrating the gold peak counts.
Radiation scattered by the sample can be used as an internal standard to correct for the
effects of self-absorption and geometrical variations on measured XRF signal (Andermann and
Kemp 1958, Bui et al 1989). We have previously demonstrated the usefulness of this technique
for this application; the accuracy of concentration measurement was found to improve by 71%
on performing the scatter correction (Ricketts et al 2012). Correction involved normalizing
to the image obtained using the integral counts of a region of interest covering the coherent
scatter peak of each spectrum. The tails of the elastic scattering peak and of the Compton
scattering peaks show an overlap that was neglected in this analysis. It should be noted that
this normalization technique is only appropriate if the scatter signal is sufficiently large such
that its Poisson statistics do not worsen the accuracy of concentration measurement.
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Figure 4. Sample energy spectra collected in two different points of the scan in pure Perspex (top)
and within the hole filled with 4 mgAu ml−1 GNP solution (bottom). Regions of interest used for
the computation of the integral counts are included on the spectra—from left to right: gold Lα line,
gold Lβ line, Compton scattering peak and elastic scattering peak.
The image reconstruction protocol did not attempt to quantify GNP concentration in
each pixel, and was undertaken to demonstrate the feasibility of forming an image of GNP
distribution. GNP concentration measurement has been previously demonstrated (Ricketts
et al 2012), and this approach collected the same information but from a smaller volume, and
therefore the ability to quantify GNP concentrations and the system detection limit should
remain unchanged if sufficient counting times are used.
2.3. One-shot system
In order to avoid step and scan XRF imaging techniques which potentially require long
measurement times, the feasibility of excitation of the whole sample with a wide beam and
detection of the XRF x-rays with a 2D energy resolving pixellated controlled drift detector
(CDD) has been investigated. Use of a collimating polycapillary optic coupled to the detector
preserves the positional information from where fluorescence was emitted. Measurements
were made at the SYRMEP beamline at the Elettra synchrotron source, Trieste, Italy. The
synchrotron source energy was set to 15 keV. A beam size was set to completely cover the
detection area of the sample (detector dimensions 4.3 mm × 6.1 mm). The sample thickness
measured was 3.8 mm, and the view area limited to the field of view of the polycapillary optic
lens and the detector area.
The imager was mounted with a 90◦ geometry and coupled with a parallel polycapillary
optic to ascertain the position of emission of gold fluorescence. A CCD camera behind the
sample monitored the beam-sample alignment and made conventional transmission images
to assist beam-sample–detector alignment. An ionization chamber was used to monitor beam
intensity. The experimental set-up is displayed in figure 5.
2.3.1. X-ray detector system. A CDD (Politecnico di Milano, INFN Milano and MPI Munich)
of pixel size 180 μm × 180 μm, and 24 drift channels each with 34 pixels was used to form
the XRF images. The CDD was coupled to a collimating polycapillary optic angular filter (IfG
Berlin), of channel size 30 μm.
The CDD was a fully depleted silicon detector that operated in single-photon counting
integrate–readout mode and allowed detection of position and energy of each photon in
the range 0.5–30 keV. High frame rates (up to 100 kHz) were achievable (Castoldi et al
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Figure 5. Experimental set-up of CDD XRF imaging system.
2007). The chip thickness was 300 μm allowing absorption efficiency of 93% for the gold
Lα line. The measured energy resolution was 320 eV at the manganese Kα line (5.9 keV).
During measurement at Elettra, the energy resolution was found to degrade to 460 eV FWHM
measured at the copper Kα line (8 keV), due to the noisy environment of a synchrotron beam.
Equally spaced potential wells were generated along the length of the detector; the charge
generated by the interacting photon was collected in these wells. The potential barriers were
then removed and the charge collected drifted towards the readout located at the end of each
column. One positional coordinate was given by drift time, the other by knowing which drift
column the event occurred. The amplitude of the signal pulse provided the energy information.
The characteristics of both the CDD and SDD systems have been compared in
table 1.
2.3.2. Collimating polycapillary optics. In order to acquire a 2D XRF image of the sample
on the detector in one shot, a detector collimator was required. The spatial resolution of an XRF
image is a summation in quadrature of the detector pixel size and the collimator hole size.
A multi-hole mechanical collimator (typically with hole dimensions limited to ∼500 μm)
may have been used. However, the hole size would have dominated the spatial resolution.
To overcome the practical limitations of mechanical collimator hole size polycapillary optic
technology was used; a parallel polycapillary optic (model 72MLS) made available by IfG
GmbH, Berlin, was implemented with glass capillary channel diameter 30 μm ± 1 μm,
bunched together in parallel to form a monolithic structure of total diameter 8 mm. The
capillaries were 40 mm in length. The capillaries were encased in a metal cylinder of outer
diameter 12 mm and total length 44 mm.
X-rays were only accepted into the optic channels if the incident angle of the x-ray was
below the critical angle for TER at that energy (θ c(E)). The proposed system used an optic
made of borosilicate glass, for which θ c(E) is:
θc(E ) = 30E mrad (1)
where E is the photon energy in keV (Wang et al 1996).
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Table 1. Characteristics of the SDD and CDD systems for use in XRF imaging. The image pixel
size of the CDD was calculated as a quadrature sum of CDD pixel size and polycapillary optic
channel size.
Parameter SDD + focusing optic CDD + collimating optic
Energy resolution 350 eV at 20 keV 1 keV average at 20 keV
Max count rate 100 kHz 100 kHz
Substrate thickness 450 μm Si 300–450 μm Si
Efficiency at Lα 97% 93–97%
Image pixel size 300 μm (focus spot size) 182 μm
θ c(E) was <5 mrad for x-rays in the 5–30 keV energy range, and the fibres therefore acted
as fine angular collimators, filtering through x-rays at the selected scatter angle and rejecting
x-rays incident at all other angles. This allowed formation of a 2D image (across the area
of the optic) of the x-rays emitted in the solid angle of collection of the optic, and therefore
enabled faster image acquisition than point-by-point scanning. Optic channel sizes of the order
of a few tens of micrometres meant that the detector pixel size (180 μm for the CDD) set the
limiting factor for the spatial resolution. Use of a parallel optic improved the spatial resolution
by a factor of ∼2.5 compared with using a typical multi-hole collimator (from ∼500 μm 10 Q5
∼180 μm).
It should be noted that the optic cannot be employed at high x-ray energies (such as for
K-XRF techniques) due to penetration of x-rays through the glass fibres; a collimator with
different glass composition could be designed with high Z components for use at high energies.
The use of the current optic is limited to application in L-XRF techniques.
2.3.3. Gold nanoparticle imaging procedure. The beam, detector and sample were aligned.
The sample image area was fully illuminated by the synchrotron beam, and the CDD set to
acquire for 6500 s for the high contrast phantom and 11 000 s for the low contrast phantom.
Regions of interest were set over the gold Lα, gold Lβ and coherent scatter peaks for each
detector pixel spectrum. The latter region of interest was set to perform a scatter normalization
to the XRF image to correct for sample absorption.
2.4. Measurements at depth
The aim of this technique is to image GNP concentrations in vivo or in thick ex vivo samples,
and so the effect of overlying tissue on the XRF signal must be determined. The L-XRF
system was used to perform a series of XRF measurements of an 8 mgAu ml−1 GNP solution
suspended in de-ionized water with five different thicknesses of Perspex (0, 2, 4, 8 and
16 mm) placed between the sample and detector (see figure 6). Perspex has similar attenuating
properties to tissue at these energies. Each measurement was acquired for 180 s.
3. Results
3.1. Step and scan system
Figure 7 displays the 2D pixellated images obtained by plotting the logarithm of the gold
Lα and Lβ peak ROIs as a function of scan position for the high contrast phantom (with
and without normalizing to the coherent scatter peak), and also the scatter normalized low
concentration phantom. The primary beam is incident on the right side of the images in figure 7.
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Figure 6. Depth measurement of 8 mgAu ml−1 GNP sample; a range of Perspex thicknesses were
added above the sample to test the effect of depth of measurement on the L-XRF method.
Figure 7. 2D gold XRF images in log scale of GNP contrast phantoms acquired using an SDD
coupled to a focusing polycapillary optic. The primary beam is incident on the right-hand side of
the images. (Left) Un-normalized high contrast phantom, (middle) scatter normalized high contrast
phantom, and (right) coherent scatter normalized low concentration phantom.
3.2. One-shot system
Two XRF images of a high contrast and low contrast phantom are displayed in figure 8.
The high contrast image in figure 8 displays presence of an iron slab alignment tool as
a cold spot on the image (i.e. very few x-rays were detected in the gold ROI at the position
of the iron). A cold spot is also present on the bottom of the low contrast image due to the
location of the lens border.
3.3. Measurements at depth
The effect of adding Perspex thickness to the measured XRF spectra is displayed in
figure 9.
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Figure 8. XRF images (log scale) of GNP contrast resolution phantom using the CDD–
polycapillary optic XRF system. The images are of high contrast (left) and low contrast (right)
details. GNP concentrations are labelled on the images.
Table 2. Predicted and measured attenuation of gold fluorescence signals through varying
thicknesses of Perspex.
Perspex Measured (predicted) Measured (predicted)
thickness (mm) gold Lα reduction % gold Lβ reduction %
2 54 (60) 38 (47)
4 77 (84) 61 (72)
8 95 (97) 84 (92)
16 99.2 (99.9) 89 (99)
Figure 9 displays only a slight difference in the background of the gold XRF signal with
increasing Perspex thickness. This is because the source was monoenergetic, and so Compton
scatter x-rays are all of a similar energy (the Compton scatter peak was found at 14.6 keV at 90◦
detection) and did not contribute to the background of the gold signal. Figure 9 demonstrates
that the gold L-XRF lines decrease in intensity with increasing Perspex thickness due to
attenuation by the Perspex. All gold signals were found to be above the DL of the system.
The predicted and measured reduction in both the gold Lα and Lβ signals due to overlying
thicknesses of Perspex is tabulated in table 2.
4. Discussion
Figures 7 and 8 demonstrated that GNP concentrations differing by factors of 20 and 5
could be distinguished by both the step and scan and one-shot XRF imaging systems. Both
systems therefore achieved the requirement needed to distinguish tumour from surrounding
healthy tissue at GNP concentrations typically expected in vivo. This study has demonstrated
the capability of the system to image GNP distribution and to distinguish between GNP
concentrations. There is a strong potential that this technique can be extended to quantitative
imaging, as this system has already demonstrated ability for quantitative measurement
to within ± 0.005 mgAu ml−1 at low concentrations (between the detection limit of
0.001 mgAu ml−1 and 0.1 mgAu ml−1) (Ricketts et al 2012).
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Figure 9. Measured L-XRF spectra of an 8 mgAu ml−1 sample acquired with a range of Perspex
thicknesses above the sample.
Figures 7 and 8 also demonstrate that both XRF imaging systems can be used to image
GNP concentrations as low as 0.025 mgAu ml−1. Lower concentrations were not tested in
this study due to restrictions on acquisition time at the synchrotron source. However it can
be inferred from previous detection limit measurements that the step and shoot system may
be sensitive to even lower concentrations (Ricketts et al 2012). The addition of polycapillary
optic technology will impact on the achievable sensitivity and detection limit in the following
ways. Use of the parallel polycapillary optic greatly reduces the collection angle of x-rays
emitted from the sample; this decreases the scatter component of the measured spectrum,
therefore reducing the background beneath the XRF peak, positively impacting on detection
limit. However, the optic also acts to reduce the count rate of the gold XRF signal, which
will reduce the sensitivity of the system. The system sensitivity will also be decreased due to
transmission losses in the optic. The transmission efficiency of optics is a function of x-ray
energy (due to the dependence of the critical angle on energy).
Use of the CDD/parallel optic system improved the achievable spatial resolution of XRF
imaging by a factor of 1.6 compared with using the SDD/focusing optic system. There were
no differences in efficiency of detection of the gold signal, or achievable count rate between
the CDD and SDD. The ∼1 keV energy resolution of the CDD was sufficient to distinguish
the gold Lα and Lβ peaks, and could also easily distinguish the scatter peaks and the gold
XRF signal. The only effect the degradation in energy resolution would have compared to the
SDD is that the detection limit of the system will worsen. A more detailed study in the future
is required to quantify the achievable detection limit of the CDD system. Use of the CDD also
enabled quicker acquisition times, as it was used to simultaneously collect the XRF spectra
for 816 pixels; in order to acquire data for an image with the same number of pixels, the SDD
system would have to perform 816 individual scans leading to acquisition times nearly three
orders of magnitude greater. 2D images may be acquired over a range of slices in order to
construct 3D images of the sample.
The crescent shape seen in the right of the left-hand image in figure 7 is due to attenuation
of the primary beam in penetrating the sample. In order to account for beam absorption a scatter
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normalization technique was implemented. The resulting normalized image in log scale is also
displayed in figure 7, and shows improved uniformity after correcting for attenuation effects.
At this stage, the imaging system does not provide absolute quantitative information of
GNP concentration. In order to achieve this in future system development, the following must
be considered.
• Partial volume effect and correction methods to account for this.
• The system must be fully calibrated so that the gold XRF signal at a known beam thickness
and solid angle is known.
• Further methods of attenuation correction should be investigated. One possibility is the
use of transmission images to measure the attenuation coefficient of each pixel in order to
perform the absorption correction.
The predicted and measured effects of overlying thicknesses of Perspex were found to be
in good agreement; differences may be attributed to the fact that measurement was not made
in narrow beam geometry. As expected the reduction in signal due to 4 (8) mm overlying
Perspex was measured to be 61% (84%) and 77% (95%) for the gold Lβ and Lα signals
respectively. Even though the Lβ signal has a lower fluorescence yield than the Lα peak, it
may be beneficial to use the Lβ peak for analysis of measurements made at depth due to its
greater energy. The penetrability of L-XRF makes it sufficient to image GNP distribution in
small-animal studies where the GNPs are distributed near the surface of the animal, and a
useful tool for imaging 3D in vitro cellular constructs. There are depth limitations to the L-
XRF imaging technique making it currently unable to image deep tumours. However K-XRF
techniques may be implemented for deeper imaging studies; the predicted reduction in gold
Kα XRF signal due to 8 mm overlying Perspex is only 16%.
Even though K-XRF systems penetrate to greater depths, they cannot achieve sensitivity
to low concentrations; a compromise must be made between GNP concentration sensitivity
and penetration depth. The L-XRF imaging system we developed demonstrated sensitivity to
GNP concentrations up to two orders of magnitude lower than that achieved by the K-XRF
XFCT system reported in the literature (Jain et al 2012); even though the fluorescence yields
for K-shells is more than a factor of 3 larger than for the L-shells, the photoelectric cross
section just above the L-edge of gold (σ (11.98 keV) = 179.1 cm2 g−1) is over 21 times greater
than that just above the K-edge (σ (81.13 keV) = 8.3 cm2 g−1) (calculated from values taken
from Chantler et al (2005)). Also, the ratio of photoelectric cross section to total scatter cross
section (corresponding to signal to noise ratio) is greater for L-XRF than K-XRF (ratios of
43.4 and 22.0 at the L-edge and K-edge energies respectively). This means that the scatter
contribution to the background beneath the gold signal for the K-XRF system is double that
for the L-XRF system, making it less sensitive to low concentration measurement.
5. Conclusions
A high detecting sensitivity to GNPs can be achieved using XRF techniques, at depths greater
than optical modalities currently used. An XRF spectrometer (SDD) coupled to polycapillary
lenses was used to define measurement volumes in order to build up pixellated images
of GNP-loaded phantoms. The feasibility of performing energy resolved imaging of GNP
distribution at concentrations relevant for in vivo and in vitro studies has been demonstrated.
GNP concentrations different by a factor of 5 have been shown to be easily resolvable, making
this system capable of distinguishing tumour from non-tumour. Further work is required to test
the contrast resolution capability of the system further. The L-XRF system can successfully
detect GNPs at depths relevant for 3D in vitro cell studies and small-animal studies up to
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centimetre tissue depths, but not currently at depths needed for imaging deep tumours in vivo.
Details of phantoms with concentrations as low as 0.025 mgAu ml−1 (the lowest concentration
present in the phantom) have been successfully imaged in this study. It can be inferred from
previous detection limit measurements that the system will have sensitivity to even lower
concentrations. In order to avoid step and scan XRF imaging techniques (potentially requiring
long measuring times) the feasibility of excitation of the whole specimen with a wide beam
and detection of the fluorescent x-rays with a pixellated energy resolving detector without
scanning has been investigated. A parallel polycapillary optic coupled with a CDD has been
successfully used to ascertain the position where fluorescence was emitted. Further work is
required to investigate methods to perform absolute quantitative imaging. This is challenging,
and will involve development of correction procedures for sample attenuation and partial
volume effect, and other calibration techniques to gain absolute concentration information.
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